{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:37:43Z","timestamp":1760708263782,"version":"3.41.2"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1111\/igc.0b013e3181b70465","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T13:48:52Z","timestamp":1291384132000},"page":"1322-1328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Expression of p53 Protein Phosphorylated at Serine 20 and Serine 392 in Malignant and Benign Ovarian Neoplasms"],"prefix":"10.1016","volume":"19","author":[{"given":"Julia K.","family":"Bar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Saomska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Rabczycki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leszek","family":"Noga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Grybov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e3181b70465_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.trsl.2006.06.001","article-title":"Differential gene expression identifies subgroups of ovarian carcinomas","volume":"148","author":"Skubitz","year":"2006","journal-title":"Transl Res."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0010","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1046\/j.1432-1327.2001.02225.x","article-title":"Post-translational modifications and activation of p53 by genotoxic stresses","volume":"268","author":"Appella","year":"2001","journal-title":"Eur J Biochem."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0015","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nrc1455","article-title":"Post-translational modification of p53 in tumorigenesis","volume":"4","author":"Bode","year":"2004","journal-title":"Nat Rev Cancer."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/cncr.11064","article-title":"A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors","volume":"97","author":"Kmet","year":"2002","journal-title":"Cancer."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.critrevonc.2006.03.003","article-title":"Molecular predictors of response and outcome in ovarian cancer","volume":"60","author":"Pierotti","year":"2006","journal-title":"Crit Rev Oncol Hematol."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0030","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.cdd.4401925","article-title":"The complexity of p53 stabilization and activation","volume":"13","author":"Lavin","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0035","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1038\/sj.onc.1204458","article-title":"Distinct pattern of p53 phosphorylation in human tumors","volume":"20","author":"Minamoto","year":"2001","journal-title":"Oncogene."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.febslet.2004.07.014","article-title":"Modification of serine 392 is a critical event in the regulation of p53 nuclear export and stability","volume":"572","author":"Kim","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0045","doi-asserted-by":"crossref","first-page":"13777","DOI":"10.1073\/pnas.96.24.13777","article-title":"Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage","volume":"96","author":"Chehab","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0050","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1038\/sj.onc.1204017","article-title":"DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo","volume":"19","author":"Jabbur","year":"2000","journal-title":"Oncogene."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0055","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.onc.1205112","article-title":"The interaction of p53 with the nuclear matrix is mediated by F-action and modulated by DNA damage","volume":"21","author":"Okorokov","year":"2002","journal-title":"Oncogene."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00432-003-0480-4","article-title":"Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents","volume":"129","author":"Mujoo","year":"2003","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00795-006-0320-0","article-title":"Posttranslational phosphorylation of mutant p53 protein in tumor development","volume":"39","author":"Matsumoto","year":"2006","journal-title":"Med Mol Morphol."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/path.1082","article-title":"Frequent phosphorylation at serine 392 in overexpressed p53 protein due to missense mutation in carcinoma of the urinary tract","volume":"197","author":"Furihata","year":"2002","journal-title":"J Pathol."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000081001","article-title":"Prognostic significance of serine 392 phosphorylation in overexpressed p53 protein in human esophageal squamous cell carcinoma","volume":"67","author":"Matsumoto","year":"2004","journal-title":"Oncology."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00432-006-0085-9","article-title":"Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junction","volume":"132","author":"Puhringer-Oppermann","year":"2006","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0085","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1158\/0008-5472.CAN-1305-2","article-title":"Ser392 phosphorylation regulates the oncogenic function of mutant p53","volume":"64","author":"Yap","year":"2004","journal-title":"Cancer Res."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0090","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1126\/science.287.5459.1824","article-title":"DNA damage-induced activation of p53 by the checkpoint kinase Chk2","volume":"287","author":"Hirao","year":"2000","journal-title":"Science."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0095","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ijc.23086","article-title":"AKT promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function","volume":"122","author":"Fraser","year":"2008","journal-title":"Int J Cancer."},{"key":"10.1111\/IGC.0b013e3181b70465_bb0100","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","article-title":"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis","volume":"434","author":"Bartkova","year":"2005","journal-title":"Nature."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e3181b70465","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24028044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24028044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:17:20Z","timestamp":1753233440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24028044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1048891X24028044"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e3181b70465","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of p53 Protein Phosphorylated at Serine 20 and Serine 392 in Malignant and Benign Ovarian Neoplasms","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e3181b70465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}